Suzanne E. Little

1.1k total citations
15 papers, 847 citations indexed

About

Suzanne E. Little is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Suzanne E. Little has authored 15 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Neurology. Recurrent topics in Suzanne E. Little's work include Renal and related cancers (7 papers), Glioma Diagnosis and Treatment (6 papers) and Prenatal Screening and Diagnostics (3 papers). Suzanne E. Little is often cited by papers focused on Renal and related cancers (7 papers), Glioma Diagnosis and Treatment (6 papers) and Prenatal Screening and Diagnostics (3 papers). Suzanne E. Little collaborates with scholars based in United Kingdom, United States and Portugal. Suzanne E. Little's co-authors include Chris Jones, Dorine A. Bax, Kathy Pritchard‐Jones, Marta Viana‐Pereira, Rui Manuel Reis, Darren Hargrave, Safa Al‐Sarraj, Jorge S. Reis‐Filho, Rachael Natrajan and Nathalie Gaspar and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Suzanne E. Little

15 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne E. Little United Kingdom 14 538 347 229 164 153 15 847
Frank Mendrzyk Germany 9 660 1.2× 372 1.1× 255 1.1× 98 0.6× 120 0.8× 10 952
Carin Lassen Sweden 21 642 1.2× 297 0.9× 187 0.8× 156 1.0× 48 0.3× 35 1.3k
Carl Koschmann United States 18 428 0.8× 530 1.5× 249 1.1× 145 0.9× 188 1.2× 79 935
Anke Waha Germany 19 967 1.8× 215 0.6× 213 0.9× 85 0.5× 72 0.5× 29 1.2k
Ruth Tatevossian United States 13 442 0.8× 675 1.9× 169 0.7× 131 0.8× 386 2.5× 29 1.0k
Alfred Yung United States 16 279 0.5× 370 1.1× 150 0.7× 179 1.1× 79 0.5× 29 672
Shoju Hiraga Japan 13 364 0.7× 175 0.5× 122 0.5× 69 0.4× 125 0.8× 18 696
Prerana Jha India 20 546 1.0× 502 1.4× 417 1.8× 139 0.8× 154 1.0× 42 969
Hilary Blair United States 12 429 0.8× 703 2.0× 319 1.4× 249 1.5× 152 1.0× 17 1.2k
M. Eva Alonso Spain 22 683 1.3× 266 0.8× 192 0.8× 85 0.5× 257 1.7× 27 1.1k

Countries citing papers authored by Suzanne E. Little

Since Specialization
Citations

This map shows the geographic impact of Suzanne E. Little's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne E. Little with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne E. Little more than expected).

Fields of papers citing papers by Suzanne E. Little

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne E. Little. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne E. Little. The network helps show where Suzanne E. Little may publish in the future.

Co-authorship network of co-authors of Suzanne E. Little

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne E. Little. A scholar is included among the top collaborators of Suzanne E. Little based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne E. Little. Suzanne E. Little is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Burford, Anna, Suzanne E. Little, Alexa Jury, et al.. (2013). Distinct Phenotypic Differences Associated with Differential Amplification of Receptor Tyrosine Kinase Genes at 4q12 in Glioblastoma. PLoS ONE. 8(8). e71777–e71777. 23 indexed citations
2.
Little, Suzanne E., Sergey Popov, Alexa Jury, et al.. (2012). Receptor Tyrosine Kinase Genes Amplified in Glioblastoma Exhibit a Mutual Exclusivity in Variable Proportions Reflective of Individual Tumor Heterogeneity. Cancer Research. 72(7). 1614–1620. 93 indexed citations
3.
Williams, Richard D., Reem Al‐Saadi, Rachael Natrajan, et al.. (2011). Molecular profiling reveals frequent gain of MYCN and anaplasia‐specific loss of 4q and 14q in wilms tumor. Genes Chromosomes and Cancer. 50(12). 982–995. 38 indexed citations
4.
Bax, Dorine A., Alan Mackay, Suzanne E. Little, et al.. (2010). A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas. Clinical Cancer Research. 16(13). 3368–3377. 110 indexed citations
5.
Gaspar, Nathalie, Lynley V. Marshall, Lara Perryman, et al.. (2010). MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase–Mediated HOX/Stem Cell Gene Signature. Cancer Research. 70(22). 9243–9252. 136 indexed citations
6.
Bax, Dorine A., Nathalie Gaspar, Suzanne E. Little, et al.. (2009). EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines. Clinical Cancer Research. 15(18). 5753–5761. 71 indexed citations
7.
Bax, Dorine A., Suzanne E. Little, Nathalie Gaspar, et al.. (2009). Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development. PLoS ONE. 4(4). e5209–e5209. 93 indexed citations
8.
Little, Suzanne E., Dorine A. Bax, María Rodríguez‐Pinilla, et al.. (2007). Multifaceted Dysregulation of the Epidermal Growth Factor Receptor Pathway in Clear Cell Sarcoma of the Kidney. Clinical Cancer Research. 13(15). 4360–4364. 30 indexed citations
9.
Natrajan, Rachael, Suzanne E. Little, Jorge S. Reis‐Filho, et al.. (2006). Blastemal/stromal expression of IGF1R in Wilms tumours is driven by increased copy number and correlates with relapse. Cancer Research. 66. 987–987. 1 indexed citations
10.
Natrajan, Rachael, Jorge S. Reis‐Filho, Suzanne E. Little, et al.. (2006). Blastemal Expression of Type I Insulin-Like Growth Factor Receptor in Wilms' Tumors Is Driven by Increased Copy Number and Correlates with Relapse. Cancer Research. 66(23). 11148–11155. 36 indexed citations
11.
Natrajan, Rachael, Suzanne E. Little, Jorge S. Reis‐Filho, et al.. (2006). Amplification and Overexpression of CACNA1E Correlates with Relapse in Favorable Histology Wilms' Tumors. Clinical Cancer Research. 12(24). 7284–7293. 32 indexed citations
12.
Little, Suzanne E., Raisa Vuononvirta, Jorge S. Reis‐Filho, et al.. (2005). Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA. Genomics. 87(2). 298–306. 82 indexed citations
13.
King‐Underwood, Linda, Suzanne E. Little, R D Clutterbuck, et al.. (2005). Wt1 is not essential for hematopoiesis in the mouse. Leukemia Research. 29(7). 803–812. 15 indexed citations
14.
Little, Suzanne E., Sandra Hanks, Linda King‐Underwood, et al.. (2004). A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome. Pediatric Nephrology. 20(1). 81–85. 18 indexed citations
15.
Little, Suzanne E., Sandra Hanks, Linda King‐Underwood, et al.. (2004). Frequency and Heritability of WT1 Mutations in Nonsyndromic Wilms' Tumor Patients: A UK Children’s Cancer Study Group Study. Journal of Clinical Oncology. 22(20). 4140–4146. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026